Jpmorgan Chase & Co »

Cidara Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Cidara Therapeutics shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.3k 106 11.94

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf (SPY)
Meta Platforms Common (META)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Broadcom Common (AVGO)
Alphabet Common (GOOGL)
Vanguard Total Intl Bond Etf Fund (BNDX)
Vanguard S&p 500 Etf idx (VOO)
Ishares Core S&p 500 Etf Fund (IVV)

View all positions for Jpmorgan Chase & Co

Top funds holding Cidara Therapeutics

Monashee Investment Management
BVF
Vanguard Group
Checkpoint Capital
Renaissance Technologies
Alethea Capital Management
5AM Venture Management
BlackRock
Geode Capital Management
Schonfeld Strategic Advisors
State Street Corporation
Us Bancorp
Russell Investments
Tower Research Capital
Manchester Capital Management

View all funds holding Cidara Therapeutics